KASO

Crizotinib is used to treat non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It works by inhibiting the abnormal proteins that promote cancer cell growth.

Key Benefits:
✅ Treats ALK-positive & ROS1-positive NSCLC
✅ Slows tumor growth and prevents spread
✅ Improves survival rates in lung cancer patients

Url- https://www.kasopharmaceuticals.com/